By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Genome British Columbia has started a new Personalized Medicine Program, which includes financial support from the non-profit BC Cancer Foundation, by awarding an initial investment of around C$9 million ($9.4 million) in funding to three studies.

The new program seeks to use genomics research to tailor improved treatments for patients, to mitigate ineffective treatments and side effects, and to use genomic knowledge in disease prevention and early diagnosis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.